About
At CYduct Diagnostics ("CYductDX"), our mission is to simplify early breast cancer detection to improve women's health. As an innovative diagnostics company, our aim is to develop, produce and market leading-edge solutions for unmet clinical needs within Women's Healthcare. Our products and services will help to assess and diagnose breast disease at its earliest stages, allowing for better clinical decisions, thus enhancing women's health and quality of life. We do this in a responsible and ethical manner with a commitment to excellence in every aspect of our business.
Technologies
Outlook
GoDaddy Hosting
WordPress.org
Varnish
Google Font API
Mobile Friendly
IoT
Keywords
breast health
wellness
medical equipment manufacturing
early detection technology
women's health
clinical trial support
healthcare equipment & supplies
retail
minimally invasive procedures
medical devices
breast fluid biomarkers
medical equipment and supplies manufacturing
intraductal assessment
liquid biopsy for breast health
real-time breast monitoring
molecular analysis
intraductal biopsy
naf analysis
b2c
clinical diagnostics
risk stratification
molecular by-products analysis
non-invasive breast diagnostics
genetic and proteomic breast fluid analysis
precision medicine in breast health
breast cancer prevention tools
molecular evolution of breast cancer
breast cancer biomarkers
breast fluid analysis
personalized breast health
Company Information
-
Employees 4
-
Founded 2020
-
Total Funding $100000
Location
1698 Post Rd E, Westport, Connecticut, United States, 06880-5604
